daunorubicin has been researched along with Enlarged Spleen in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colovic, M; Floros, KV; Gourgiotis, D; Pavlovic, S; Scorilas, A; Thomadaki, H; Tosic, N | 1 |
| Baer, MR; Block, AW; Bloomfield, CD; Carroll, AJ; Farag, SS; Koduru, PR; Kolitz, JE; Larson, RA; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Stamberg, J; Stone, RM; Vardiman, JW | 1 |
| Annaloro, C; Baldini, L; Lambertenghi-Deliliers, G; Maiolo, AT; Pogliani, E; Polli, E | 1 |
| Conter, V; Dell'Orto, M; Ferrari, E; Jankovic, M; Malberti, R; Milani, M; Rizzari, C | 1 |
| Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Mandelli, F; Martinelli, G; Mecucci, C; Petti, MC; Piccaluga, PP; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Tura, S; Visani, G | 1 |
| Brun, B; Dreyfus, B; Imbert, M; Reyes, F; Rochant, H; Sultan, C; Tulliez, M; Vernant, JP | 1 |
| Baccarani, M; Bagnara, GP; Tura, S | 1 |
| Lee, SL; Rosner, F | 1 |
| Begemann, H; Gerhartz, H | 1 |
1 review(s) available for daunorubicin and Enlarged Spleen
| Article | Year |
|---|---|
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Translocation, Genetic; Treatment Outcome | 2001 |
1 trial(s) available for daunorubicin and Enlarged Spleen
| Article | Year |
|---|---|
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Splenomegaly; Survival Analysis; Treatment Outcome | 2005 |
7 other study(ies) available for daunorubicin and Enlarged Spleen
| Article | Year |
|---|---|
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cytarabine; Daunorubicin; Etoposide; Gene Expression; Gene Expression Regulation, Neoplastic; Hepatomegaly; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Muscle Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Splenomegaly; Treatment Outcome; Up-Regulation; Young Adult | 2012 |
Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Lymphoid; Leukocyte Count; Male; Middle Aged; Prednisone; Splenomegaly; Vincristine | 1984 |
Transient myeloproliferative disorder associated with trisomy 21: is a short course of chemotherapy indicated in patients with liver impairment and severe clinical problems?
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Drug Administration Schedule; Dyspnea; Fever; Hepatomegaly; Humans; Infant, Newborn; Male; Muscle Weakness; Myeloproliferative Disorders; Nutrition Disorders; Splenomegaly | 1999 |
[Acute monoblastic leukemia. Clinical and therapeutic aspects in 20 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Gingiva; Humans; Hypokalemia; Leukemia, Monocytic, Acute; Male; Middle Aged; Muramidase; Potassium; Splenomegaly | 1976 |
[Therapy of the blastic crisis].
Topics: Adolescent; Adult; Aged; Busulfan; Chromosome Aberrations; Daunorubicin; Female; Fever; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Prednisone; Splenomegaly; Time Factors | 1972 |
Treatment of AGL.
Topics: Adult; Afibrinogenemia; Aged; Anemia; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Humans; Hydroxyzine; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Mercaptopurine; Methotrexate; Middle Aged; Polycythemia Vera; Prednisone; Primary Myelofibrosis; Splenomegaly; Vincristine | 1969 |
Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
Topics: Asparaginase; Blood Chemical Analysis; Blood Platelets; Blood Sedimentation; Body Weight; Central Nervous System Diseases; Daunorubicin; Erythrocyte Count; Hepatomegaly; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Nausea; Splenomegaly; Time Factors; Vincristine; Vomiting | 1970 |